Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt

Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.

Verista Expands Automation and Validation Capabilities with Acquisition of Integral Solutions

Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announced the acquisition of Integral Solutions. Based in Columbus, OH, Integral Solutions is a life sciences business and technology services firm that specializes in engineering and validation services worldwide. The acquisition enhances Verista’s capabilities in automation, engineering, project management, and validation, enabling the company to deliver further comprehensive support across the full lifecycle of regulated life sciences operations.

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics 

Veeva Announces Environmental Monitoring Solution to Modernize Quality Control in Manufacturing

PSI Expands Toronto Operations with New Office and Appoints David Allen as Canada Country Manager

Somite Becomes Cellular Intelligence, as It Builds the First Universal Virtual Cell-Signaling Model

New white paper details key technical milestones and validation of the company’s proprietary, capsule-based platform to accelerate breakthroughs across human health

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

● Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia ● System strengthens Taiwan’s capabilities in protein drug discovery research

PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma

PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.

Panther Life Sciences Opens Next-Generation Microarray Patch (MAP) Platform to Pharma and Biotech Partners for Co-Development of Advanced Therapies

Panther is inviting pharmaceutical and biotechnology partners to co-develop higher-efficacy, lower-toxicity, shelf-stable therapies using its next-generation MAP platform, ahead of the 2026 JPMorgan Healthcare Conference.

TeleTracking Appoints Derek Ritchea as Chief Strategy Officer

CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing

Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media

ZeOmega Recognized in 2025 Gartner® Market Guide for U.S. Healthcare Payer Care Management Workflow Applications

Biopharma PEG Expands End-to-End PEGylated Protein Development Services

Biopharma PEG announced the expansion of its professional PEGylated protein development services, offering integrated, end-to-end solutions from recombinant protein expression to high-purity PEG conjugation and comprehensive analytical characterization.

Sanome announces two UK hospital partnerships to deploy AI-powered clinical intelligence for earlier infection detection

Neupulse launches first-of-its-kind wearable with the support of Ensera Design to help people living with Tourette Syndrome

AI unlocks unparalleled efficiency gains in Flare™ V11, Cresset’s leading software solution for digital molecular discovery

Flare V11 features AI generative chemistry technology, enabling researchers to generate new, diverse, drug-like molecules, while new AI Assistants unlock efficiency gains in the user experience and automate the creation of custom workflows.

CluePoints Scoops Prestigious 2025 Scrip Award

CluePoints, provider of leading statistical and AI-driven software solutions, has won the ‘Best Contract Research Organization– Specialist Providers’ category at the 2025 Scrip Awards.

eClinical Solutions Unveils AI Agents to Power the Next Era of Clinical Data Automation

Built directly into the elluminate ecosystem, the agents combine governed data with explainable intelligence to accelerate decisions

4D Path Collaborates with AMD and Oracle to Scale Predictive Oncology

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced a collaboration with AMD and Oracle to advance predictive oncology and accelerate clinical trials. Using AMD EPYC™ CPUs on Oracle Cloud Infrastructure (OCI), 4D Path’s QPOR™ platform—a physics-informed, AI-driven, deterministic software engine—can convert routine biopsy images into interpretable biomarkers of tumor and immune response faster and at lower cost.

New York Gastroenterology Associates Taps Proscia for Digital Pathology

New York Gastroenterology Associates, LLP , New York City’s leading independent gastroenterology practice, is working with Proscia®, a pathology AI company, to advance its standard of excellence.